A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 4, 2014, Pages 658-669

  Ahsan, Habibul ^a,b   Halpern, Jerry ^c   Kibriya, Muhammad G ^a   Pierce, Brandon L ^a   Tong, Lin ^a   Gamazon, Eric ^b   McGuire, Valerie ^c   Felberg, Anna ^c   Shi, Jianxin ^g   Jasmine, Farzana ^a   Roy, Shantanu ^a   Brutus, Rachelle ^a   Argos, Maria ^a   Melkonian, Stephanie ^a   Chang Claude, Jenny ⁿ   Andrulis, Irene ^u   Hopper, John L ^w   John, Esther M ^c,d,e   Malone, Kathi ^h   Ursin, Giske ^z   Gammon, Marilie D ⁱ   Thomas, Duncan C ^f   Seminara, Daniela ^g   Casey, Graham ^f   Knight, Julia A ^u   Southey, Melissa C ^w,x   Giles, Graham G ^w,y   Santella, Regina M ^j   Lee, Eunjung ^f   Conti, David ^f   Duggan, David ^k   Gallinger, Steve ^v   Haile, Robert ^f   Jenkins, Mark ^y   Lindor, Noralane M ^l   Newcomb, Polly ^h   Michailidou, Kyriaki ^aa   Apicella, Carmel ^w   Park, Daniel J ^x   Peto, Julian ^ab   Fletcher, Olivia ^ac   Silva, Isabel Dos Santos ^ab   Lathrop, Mark ^ad,ae   Hunter, David J ^m   Chanock, Stephen J ^g   Meindl, Alfons ^o   Schmutzler, Rita K ^q   Müller Myhsok, Bertram ^p   Lochmann, Magdalena ^o   Beckmann, Lars ^r   Hein, Rebecca ^n,q   Makalic, Enes ^w   Schmidt, Daniel F ^w   Bui, Quang Minh ^w   Stone, Jennifer ^w   Flesch Janys, Dieter ^s   Dahmen, Norbert ^t   Nevanlinna, Heli ^af   Aittomäki, Kristiina ^af   Blomqvist, Carl ^af   Hall, Per ^ag   Czene, Kamila ^ag   Irwanto, Astrid ^ah   Liu, Jianjun ^ah   Rahman, Nazneen ^ac   Turnbull, Clare ^ac   Dunning, Alison M ^aa   Pharoah, Paul ^aa   Waisfisz, Quinten ^ai   Meijers Heijboer, Hanne ^ai   Uitterlinden, Andre G ^aj   Rivadeneira, Fernando ^aj   Nicolae, Dan ^b   Easton, Douglas F ^aa   Cox, Nancy J ^a,b   Whittemore, Alice S ^c,d   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

^e CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ IL   (United States)

^j Epidemiology and Genetics Research Program National Cancer Institute ^*  (United States)

^k TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^l MAYO CLINIC   (United States)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^p MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^q UNIVERSITY OF COLOGNE   (Germany)

^r Institute for Quality and Economic Efficiency in Health Care   (Germany)

^s UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^t JOHANNES GUTENBERG UNIVERSITY   (Germany)

^u MOUNT SINAI HOSPITAL   (Canada)

^v MOUNT SINAI HOSPITAL   (Canada)

^w UNIVERSITY OF MELBOURNE   (Australia)

^x UNIVERSITY OF MELBOURNE   (Australia)

^y CANCER EPIDEMIOLOGY CENTRE   (Australia)

^z CANCER REGISTRY OF NORWAY   (Norway)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^ac INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ad CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^ae FONDATION JEAN DAUSSET CEPH   (France)

^af UNIVERSITY OF HELSINKI   (Finland)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah GENOME INSTITUTE OF SINGAPORE   (Singapore)

^ai VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^aj ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; PHOSPHOFRUCTOKINASE MUSCLE; UNCLASSIFIED DRUG; 6 PHOSPHOFRUCTOKINASE ISOENZYME M; PFKM PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGE; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CAUCASIAN; CHROMOSOME 12Q; CHROMOSOME 5Q; CONTROLLED STUDY; EARLY ONSET BREAST CANCER; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LATER ONSET BREAST CANCER; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION DYNAMICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; BREAST NEOPLASMS; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898730826     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0340     Document Type: Article

References (68)

1. Narod SA. Early-onset breast cancer: what do we know about the risk factors?: A countercurrents series. Curr Oncol 2011;18:204-5.
2. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
3. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003;95:448-57. (Pubitemid 36432419)
4. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 1997;60:496-504. (Pubitemid 27097597)
5. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8. (Pubitemid 24336346)
6. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358: 1389-99.
7. Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, et al. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol Biomarkers Prev 2006; 15:359-63. (Pubitemid 43342188)
8. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, et al. A catalog of published genome-wide association studies. [accessed Sept 2012]. Available from: www.genome.gov/gwastudies.
9. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6: R375-89.
10. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H. Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control 2000;11:687-95.
11. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002;74:235-54. (Pubitemid 34848352)
12. Friedrichsen DM, Malone KE, Doody DR, Daling JR, Ostrander EA. Frequency of CHEK2 mutations in a population-based case-control study of breast cancer in young women. Breast Cancer Res 2004;6: R629-35.
13. Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, et al. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Cancer Epidemiol Biomarkers Prev 2008;17:3170-8.
14. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2331-43. (Pubitemid 351196365)
15. Figueiredo JC, Lewinger JP, Song C, Campbell PT, Conti DV, Edlund CK, et al. Genotype-environment interactions in microsatellite stable/microsatellite instability-low colorectal cancer: results from a genome-wide association study. Cancer Epidemiol Biomarkers Prev 2011;20: 758-66.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007;81:559-75. (Pubitemid 47330214)
17. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9. (Pubitemid 44141658)
18. Browning BL, Browning SR. Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Genet Epidemiol 2007;31:365-75. (Pubitemid 47050999)
19. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
20. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010;6:e1000888.
21. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al. SCAN: SNP and copy number annotation. Bioinformatics 2010;26:259-62.
22. Duan S, Huang RS, Zhang W, Bleibel WK, Roe CA, Clark TA, et al. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 2008;82:1101-13.
23. De la Cruz O, Wen X, Ke B, Song M, Nicolae DL. Gene, region and pathway level analyses in whole-genome studies. Genet Epidemiol 2010;34:222-31.
24. Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF. kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust 2000;172:463-4.
25. Fletcher O, Johnson N, Palles C, dos Santos Silva I, McCormack V, Whittaker J, et al. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2006;98:1014-8. (Pubitemid 44288167)
26. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 2006;35:34-41. (Pubitemid 43205440)
27. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
28. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-7.
29. Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 2010;11:134.
30. Cochran BG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
31. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4. (Pubitemid 47014500)
32. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-84.
33. Fisher RA. Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd; 1925.
34. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys M, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90.
35. Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93. (Pubitemid 47014426)
36. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Vilae A, Garber J, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A 2008; 105:4340-5. (Pubitemid 351754382)
37. Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 2010;31:1417-23.
38. Boyarskikh UA, Zarubina NA, Biltueva JA, Sinkina TV, Voronina EN, Lazarev AF, et al. Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia. Eur J Hum Genet 2009;17:1688-91.
39. Jia C, Cai Y, Ma Y, Fu D. Quantitative assessment of the effect of FGFR2 gene polymorphismon the risk of breast cancer. Breast Cancer Res Treat 2010;124:521-8.
40. Raskin L, Pinchev M, Arad C, Lejbkowicz F, Tamir A, Rennert HS, et al. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomarkers Prev 2008;17:1060-5.
41. Li J, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, et al. A genome-wide association scan on estrogen receptor-negative breast cancer. Breast Cancer Res 2010;12:R93.
42. Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 2010;19:2357-65.
43. Reeves GK, Travis RC, Green J, Bull D, Tipper S, Baker K, et al. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA 2010;304: 426-34.
44. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 2011;103:425-35.
45. Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, Maranian M, et al. Fine scale mapping of the breast cancer 16q12 locus. Hum Mol Genet 2010;19:2507-15.
46. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility loci at 6q25.1. Nat Genet 2008;41:324-8.
47. Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 2008;29:2341-6.
48. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson A, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9. (Pubitemid 47014497)
49. Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 2010;6:e1001183.
50. Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Identi fication of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet 2010;6: e1001002.
51. Udler MS, Meyer KB, Pooley KA, Karlins KA, Struewing J, Zhang J, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 2009;18:1692-703.
52. Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet 2011;20:4991-9.
53. Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah PDP, et al. Acombined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 2011;126:717-27.
54. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson S, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-6. (Pubitemid 351748861)
55. Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 2010;6: e1001029.
56. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012;21:5373-84.
57. Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, et al. A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 2013;132:39-48.
58. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013;45: 392-8.
59. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013;45:371-84.
60. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353-61.
61. Tarui S, Okuno G, Ikura Y, Tanaka T, Suda M, Nishikawa M. Phosphofructokinase deficiency in skeletal muscle. A new type of Glycogenosis. Biochem Biophys Res Com 1965;19:517-23.
62. Vasconcelos O, Sivakumar K, Dalakas MC, Quezado M, Nagle J, Leon-Monzon M, et al. Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease. Proc Natl Acad Sci U S A 1995;92:10322-6.
63. Garcia M, Pujol A, Ruzo A, Riu E, Ruberte J, Arbos A, et al. Phospho-fructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet 2009;5:e1000615.
64. Zancan P, Sola-Penna M, Furtado CM, Da Silva D. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol Genet Metab 2010;100:372-8.
65. Smerc A, Sodja E, Legisa M. Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism. PLoS ONE 2011;6:e19645.
66. Danilova N, Kumagai A, Lin J. p53 upregulation is a frequent response to deficiency of cell-essential genes. PLoS ONE 2010;5: e15938.
67. Deng H, Yu F, Chen J, Zhao Y, Xiang J, Lin A. Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1. J Biol Chem 2008;283:20754-60.
68. Usenik A, Legisa M. Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase. PLoS ONE 2010;5:e15447.